Fintel reports that on September 9, 2026, Leerink Partners initiated coverage of Nautilus Biotechnology (NASDAQCM:NAUT) with a Outperform recommendation. Prior to this rating action, the stock closed ...

Matica Biotechnology ("Matica Bio"), a Texas-based contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced a collaboration with Bondwell ...

Scientists at the Department of Energy (DOE)'s Oak Ridge National Laboratory (ORNL) have shown that more than 93% of possible E. coli CRISPR-Cas9 guide RNAs—molecules that direct the gene-editing ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Nautilus Biotechnology, Inc. ( NAUT ), a development-stage life sciences company focused on single-molecule proteomics, on Friday announced a peer-reviewed publication in Nature Methods demonstrating ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Shulkin was the ninth secretary of the U.S. Department of Veterans Affairs in the Trump administration and undersecretary for health in the Obama administration. Biotechnology is rapidly becoming a ...

China is simply building up its technological capabilities, strengthening its domestic industrial chains, and pursuing steady ...

Industrial biotechnology has the potential to save the planet up to 2.5 billion tons of CO2 emissions per year and support building a sustainable future, a WWF report found. Industrial biotechnology ...

Imagine bacteria that could spread through our bodies to scavenge mercury or other pollutants and then extrude them from a pimple. Or plants that continue to photosynthesise under very low light ...

Malawi and Nigeria will compare agricultural biotechnology experiences at an African Seed Trade Association webinar on 8 ...

Launched on June 19, 2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the ...